期刊文献+

2型糖尿病患者血皮质醇与非酒精性脂肪性肝病的相关性研究 被引量:1

Relationship between serum cortisol and non-alcoholic fatty liver disease in type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨2型糖尿病(T2DM)患者血皮质醇与非酒精性脂肪性肝病(NAFLD)的关系.方法回顾性分析2018年9月~2019年6月于我科住院治疗的614例T2DM患者的临床资料,根据肝脏瞬时弹性成像结果将患者分为T2DM组(328例)及T2DM合并NAFLD组(286例),比较并分析患者的一般资料及实验室相关指标.结果T2DM合并NAFLD组患者的BMI、血压、胰岛素抵抗指数(HOMA-IR)、午夜0时皮质醇[F(0)]、ALT、AST、γ-谷氨酰转肽酶(γ-GT)及甘油三酯(TG)均明显高于T2DM组(P<0.05),而高密度脂蛋白胆固醇(HDL-C)、载脂蛋白(apo)A及糖尿病病程均明显低于T2DM组(P<0.01).Logistic回归分析结果显示,F(0)是T2DM合并NAFLD的独立危险因素(OR=1.006,P<0.001).F(0)最高三分位组(T3组)NAFLD患病率明显高于其余两组(P<0.05).F(0)联合BMI、ALT预测T2DM患者发生NAFLD的受试者工作特征(ROC)曲线下面积为0.758(95%CI 0.72~0.95).结论T2DM患者血F(0)与NAFLD密切相关,血F(0)升高是NAFLD的独立危险因素. Objective To study the association between serum cortisol and nonalcoholic fatty liver disease(NAFLD)in patients with type 2 diabetes mellitus(T2DM).Methods A total of 614 T2DM inpatients in our department from September 2018 to June 2019 were selected and their clinical data were retrospectively analyzed.They were divided into T2DM+NAFLD group(n=286)and T2DM group(n=328)based on the measurement with liver transient elastography.Data of demographics tind laboratory measurements were compared and analyzed.Results Compared to the patients in T2DM group,subjects of T2DM+NAFIJD group had markedly higher BMI,blood pressure,insulin resistance index(HOMA-IR),midnight cortisol[F(0)],ALT,AST,γ-glutamyl transpeptadase(γ-GT),triglyceride(TG)levels(P V0.05),and lower high density lipoprotein cholesterol(HDL-C),apolipoprotein(apo)A and diabetes duration(P<0.01).Logistic regression analysis revealed that F(0)was an independent risk factor for NAFLD(OR=1.006,P<0.001).The prevalence of NAFLD in the highest F(0)tertile group(group T3)was significantly higher than those of other two groups(P<0.05).Area under receiver operating characteristic(ROC)curve of F(0)combined with BMI and ALT predicting NAFLD in patients with T2DM was 0.758(95%CI 0.72-0.95).Conclusion In T2DM patients,serum F(0)is inseparably associated with NAFLD.Increased serum F(0)is an independent risk factor for NAFLD.
作者 常明星 顾天伟 朱大龙 Chang Mingxing;Gu Tianwei;Zhu Dalong(Department of Endocrinology,Nanjing Drum Tower Hospital,Graduate School of Peking Union Medical College and Chinese Academy of Medical Science,Nanjing 210008,China;不详)
出处 《临床内科杂志》 CAS 2020年第3期166-169,共4页 Journal of Clinical Internal Medicine
基金 江苏省重点研发计划(社会发展)重点病种规范化诊疗项目(BE2015604) 江苏省卫生计生委医学科研课题(Q2017006)。
关键词 2型糖尿病 皮质醇 非酒精性脂肪性肝病 Tvpe 2 diabetes mellitus Cortisol Non-alcoholic fatty liver disease
  • 相关文献

参考文献3

二级参考文献31

  • 1Paschalis Paschos,Konstantinos Tziomalos.不含酒精的脂肪肝疾病和高血压蛋白原酶血管收缩素系统: 为治疗的含意[J].World Journal of Hepatology,2012,4(12):327-331. 被引量:12
  • 2Gathercole LL, Lavery GG, Morgan SA, et al. 11 beta-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects. Endocr Rev, 2013,34: 525-555.
  • 3Edwards CR,Stewart PM, Burt D,et al. Localisation of 11 betahydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. Lancet, 1988,2: 986-989.
  • 4Kannisto K,Pietilainen KH,Ehrenborg E,et al. Overexpression of 11 beta- hydroxysteroid dehydrogenase-I in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. J Clin Endocrinol Metab,2004,89:4414-4421.
  • 5Olza J , Gil-Campos M, Leis R, et al. A gene variant of 11betahydroxysteroid dehydrogenase type 1 is associated with obesity in children.lnt] ObesvLond) ,2012,36:1558-1563.
  • 6Livingstone DE, Grassick SL,Currie GL,et al. Dysregulation of glucocorticoid metabolism in murine obesity: comparable effects of leptin resistance and deficiency.] Endocrinol,2009,201:211- 218.
  • 7Seckl]R,Morton NM,Chaprnan KE, et al. Glucocorticoids and 11 beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res,2004,59:359-393.
  • 8Paterson JM, Morton NM, Fievet C, et al. Metabolic syndrome without obesity: Hepatic overexpression of 11 beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Nat! Acad Sci USA, 2004 ,101: 7088-7093.
  • 9Masuzaki Hv Paterson] ,Shinyama H,et al. A transgenic model of visceral obesity and the metabolic syndrome. Science, 2001, 294:2166-2170.-.
  • 10Kotelevtsev Y, Holmes MC,Burchell Avet al. l l beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Nat! Acad Sci USA, 1997, 94: 14924-14929.

共引文献186

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部